Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries

NCT05183399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-01-10

No results posted yet for this study

Summary

The purpose of this study is to confirm device efficacy and safety of the GORE® VIABAHN® Endoprosthesis (hereafter "VB device") for the treatment of traumatic or iatrogenic vessel injury in thoracic, abdominal, and pelvic arteries (except the aorta, coronary, brachiocephalic, carotid, vertebral and pulmonary arteries).

Conditions

  • Iatrogenic Vessel Injury

Interventions

DEVICE

GORE® VIABAHN® Endoprosthesis

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-05-19
Completion
2021-02-14
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183399 on ClinicalTrials.gov